Caring Brands (CABR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 May, 2026Executive summary
Special Meeting scheduled for July 7, 2026, to vote on four key proposals related to capital structure and financing.
Proposals include approving additional investment rights, share issuance above 19.99%, increasing authorized common stock, and potential adjournment to solicit more proxies.
Board unanimously recommends voting in favor of all proposals.
Voting rights are one vote per share; record date is May 14, 2026, with 9,091,506 shares outstanding.
Proxy materials are available online, and shareholders can vote by mail, phone, or internet.
Voting matters and shareholder proposals
Proposal 1: Approve Additional Investment Right for purchasers to buy more Series A Preferred Stock and Warrants, potentially diluting existing shareholders.
Proposal 2: Authorize issuance of common stock upon conversion of Series A Preferred Stock and Warrants, exceeding 19.99% of outstanding shares.
Proposal 3: Amend Articles of Incorporation to increase authorized common stock from 100M to 500M shares.
Proposal 4: Approve adjournment of the meeting if more time is needed to solicit proxies.
Board recommends voting “FOR” all proposals.
Board of directors and corporate governance
Board consists of Dr. Glynn Wilson, Brian S John, Dr. Hector Alila, Christopher Galeta, and Christopher Melton.
No director or executive officer has a substantial interest in the proposals beyond that of other shareholders.
Latest events from Caring Brands
- Minimal revenue, rising losses, and Nasdaq delisting risk amid PIPE financing and share repurchases.CABR
Q2 2026 - Record date for annual meeting corrected to May 14, 2026; only those shareholders may vote.CABR
Proxy filing - Stockholders to vote on key proposals for capital structure, Nasdaq compliance, and future flexibility.CABR
Proxy filing - No revenue, higher losses, PIPE financing, share buybacks, and Nasdaq compliance risks in Q1 2026.CABR
Q1 2026 - Early-stage wellness company faces significant losses and going concern risk amid market expansion.CABR
Registration filing - 2025 saw minimal revenue, a $6.28M net loss, and major impairments despite a successful IPO.CABR
Q4 2025 - IPO seeks $4M for wellness product growth amid losses and high market competition.CABR
Registration Filing - IPO seeks $3.2M to fund wellness product launches amid high risk and competitive market.CABR
Registration Filing - Raising $3.2M in IPO to fund wellness product launches amid ongoing losses and high risk.CABR
Registration Filing